This page contains brief information about imiquimod and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Imiquimod is approved to treat:
- Actinic keratosis in immunocompetent adults.This use is approved for the Aldara and Zyclara brands of imiquimod.
- Basal cell carcinoma that is superficial. It is used in immunocompetent adults. This use is approved for the Aldara brand of imiquimod.
- Genital warts or perianal warts in adults and in children aged 12 years and older. This use is approved for the Aldara and Zyclara brands of imiquimod.
Imiquimod is also being studied in the treatment of other conditions and types of cancer.
More About Imiquimod
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Imiquimod - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Imiquimod - Check for trials from NCI's list of cancer clinical trials now accepting patients.